Dental implants look and function like natural teeth, providing a long-lasting solution for tooth loss
Sources Nature Medicine: Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial PubMed: Tirzepatide Once Weekly for the Treatment of Obesity Cleveland Clinic Journal of Medicine: Tirzepatide adds significant weight loss even after lifestyle changes MedicalNewsToday: How to Travel with Zepbound FDA Label: MOUNJARO (Tirzepatide Injection) Medication Guide FDA Label: ZEPBOUND (Tirzepatide Injection) Medication Guide Important Medical Information and Disclaimers Important Current Status Update : On March 19, 2025, the FDA ended enforcement discretion for compounded tirzepatide
10.1056/NEJMoa1607141 19 MeierJ
199 YamadaY.IshizakiM.KidoT.HondaR.TsuritaniI.IkaiE.et al (1991)
The most reliable non-laboratory indicator of degradation is reduced effectiveness
Obesity is increasingly recognized as a chronic medical condition that can lead to a wide range of adverse health outcomes, including heart disease, diabetes, certain cancers, and more